Related references
Note: Only part of the references are listed.
Review
Biotechnology & Applied Microbiology
Jixin Liu et al.
Summary: The ability to transfer therapeutic payloads to specific muscles in a safe and efficient manner through a minimally invasive route is a crucial goal in human gene therapy. Recombinant adeno-associated viruses (AAVs) have been extensively used for this purpose, either delivering cargoes in various wild-type capsids or synthetic protein shells. This study provides an overview of commonly used techniques to enrich muscle-specific AAV capsids, including genetic diversification, stratification of capsid libraries, and alternative strategies such as ancestral reconstruction or rational design. Recent advancements have led to the discovery of myotropic vectors with unprecedented in vivo efficiency and specificity in striated muscles. Future improvements include optimal translation in humans and minimizing off-target effects.
HUMAN GENE THERAPY
(2023)
Article
Medicine, Research & Experimental
Andreas C. Chai et al.
MOLECULAR THERAPY-NUCLEIC ACIDS
(2023)
Article
Engineering, Biomedical
Jessie R. Davis et al.
Summary: Compact adenine base editors (ABEs) encoded within size-optimized genomes of adeno-associated viruses (AAVs) enable therapeutic base editing in mice at low doses and high editing efficiencies, simplifying AAV production and characterization.
NATURE BIOMEDICAL ENGINEERING
(2022)
Review
Biotechnology & Applied Microbiology
Eunyoung Choi et al.
Summary: The CRISPR-Cas system shows potential in treating Duchenne muscular dystrophy (DMD), but challenges in developing more efficient therapeutic approaches and delivery methods remain.
Article
Multidisciplinary Sciences
F. Chemello et al.
Summary: This study demonstrated the use of adenine base editor to restore dystrophin expression in cardiomyocytes affected by Duchenne muscular dystrophy mutation, as well as reframing the dystrophin open reading frame. In vivo experiments with mice showed successful gene editing and disease correction, indicating the potential of nucleotide editing for diverse DMD mutations with minimal genome modification.
Article
Multidisciplinary Sciences
Li Xu et al.
Summary: Recent advances in base editing have allowed for precise correction of disease-causing mutations, but challenges remain in terms of the size of base editors and their off-target activities, as well as the requirement for a specific protospacer adjacent motif (PAM) nearby the mutation site. This study successfully modified an NG-targeting adenine base editor to overcome these challenges and demonstrated its high efficiency in editing a Duchenne muscular dystrophy (DMD) mutation in adult mice, showing promising results with systemic delivery. The authors' approach shows potential for the treatment of monogenic diseases using base editing techniques, addressing limitations in targeting feasibility and packaging capacity.
NATURE COMMUNICATIONS
(2021)
Article
Biotechnology & Applied Microbiology
Michelle F. Richter et al.
NATURE BIOTECHNOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Christopher E. Nelson et al.
Article
Multidisciplinary Sciences
Killian S. Hanlon et al.
NATURE COMMUNICATIONS
(2019)
Article
Biotechnology & Applied Microbiology
Michael Kosicki et al.
NATURE BIOTECHNOLOGY
(2018)